SEQUANA THERAPEUTICS INC (CIK: 0000946736) EDGAR, Information, Filings... CompaniesBIO.Com

SEQUANA THERAPEUTICS INC

Mailing address
, , California,
Phone
6194526550
State location
California
State of incorporation
California
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

SEQUANA THERAPEUTICS INC (CIK: 0000946736) is an American company incorporated in the state of California. Head office is located at 11099 NORTH TORREY PINES RD, SUITE 160, LA JOLLA, California, 92037. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. SEQUANA THERAPEUTICS INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SEQUANA THERAPEUTICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-98-001052 ( Act) Size: KB	Feb-11-1998	005-49547 98530902
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000891618-98-000069 ( Act) Size: KB	Jan-09-1998	000-26244 98503902
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000928385-97-002017 ( Act) Size: KB	Dec-10-1997	005-49547 97735287
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-97-004804 ( Act) Size: KB	Dec-02-1997	000-26244 97731373
8-K/A	Document	Amendment to Current report filing Acc-no: 0000891618-97-004793 ( Act) Size: KB	Dec-02-1997	000-26244 97730816
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000891618-97-004707 ( Act) Size: KB	Nov-17-1997	005-49547 97722681
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000936392-97-001524 ( Act) Size: KB	Nov-14-1997	000-26244 97720002
8-K	Document	Current report filing Acc-no: 0000891618-97-004549 ( Act) Size: KB	Nov-12-1997	000-26244 97713774
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000891618-97-004534 ( Act) Size: KB	Nov-12-1997	005-49547 97713268
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000891618-97-003633 ( Act) Size: KB	Aug-29-1997	333-34601 97672418
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000936392-97-001097 ( Act) Size: KB	Aug-13-1997	000-26244 97658488
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000936392-97-000972 ( Act) Size: KB	Jul-30-1997	000-26244 97647927
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000936392-97-000968 ( Act) Size: KB	Jul-29-1997	000-26244 97647345
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000936392-97-000724 ( Act) Size: KB	May-15-1997	000-26244 97607903
DEF 14A	Document	Definitive proxy statements Acc-no: 0000936392-97-000569 ( Act) Size: KB	Apr-29-1997	000-26244 97589946
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000936392-97-000427 ( Act) Size: KB	Mar-31-1997	000-26244 97568485
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000891618-97-000933 ( Act) Size: KB	Feb-27-1997	333-22471 97545823
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001029869-97-000161 ( Act) Size: KB	Feb-14-1997	005-49547 97533114
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001029869-97-000150 ( Act) Size: KB	Feb-14-1997	005-49547 97532938
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000888002-97-000180 ( Act) Size: KB	Feb-14-1997	005-49547 97534182

Recent 20 filings. View all SEQUANA THERAPEUTICS INC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

SEQUANA THERAPEUTICS INC overview
SEQUANA THERAPEUTICS INC job
SEQUANA THERAPEUTICS INC stock
SEQUANA THERAPEUTICS INC ownership
SEQUANA THERAPEUTICS INC CEO
SEQUANA THERAPEUTICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.